PanGen Biotech Inc. (KOSDAQ:222110)
5,360.00
+50.00 (0.94%)
At close: Jan 23, 2026
PanGen Biotech Market Cap
PanGen Biotech has a market cap or net worth of 75.3 billion as of January 30, 2026. Its market cap has increased by 2.24% in one year.
Market Cap
75.30B
Enterprise Value
62.99B
Revenue
15.27B
Ranking
n/a
PE Ratio
44.02
Stock Price
5,360.00
Market Cap Chart
Since March 11, 2016, PanGen Biotech's market cap has decreased from 171.29B to 75.30B, a decrease of -56.04%. That is a compound annual growth rate of -7.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 75.30B | -0.36% |
| Dec 30, 2025 | 75.57B | 2.79% |
| Dec 30, 2024 | 73.52B | 0.08% |
| Dec 28, 2023 | 73.46B | 5.85% |
| Dec 29, 2022 | 69.40B | -30.44% |
| Dec 30, 2021 | 99.78B | 1.96% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 91.91B |
| Choong Ang Vaccine Laboratory | 90.71B |
| Shaperon | 89.39B |
| Naturalendo Tech | 88.41B |
| Quratis | 87.10B |
| CHA Vaccine Research Institute | 80.60B |
| HLB Pep | 78.06B |
| Ark Solutions | 68.91B |